http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201106753-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62783993487be3a09c84834bec63b46d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 |
| filingDate | 2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c725458fc59f8b2819ed29d18ada0d6f |
| publicationDate | 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TR-201106753-A2 |
| titleOfInvention | Topical therapeutic formulations. |
| abstract | The present invention relates to an antifungal, preferably amorolfine, and / or pharmaceutically acceptable salts, solvates, enantiomers, polymorphs of the morpholine group that inhibit fungal ergosterol biosynthesis, including fungal infections, candida albicans infections, dermatophyte infections and onychomycosis, dermatomycosis and other mycoses. The present invention relates to a pharmaceutical composition formulated for topical administration. |
| priorityDate | 2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.